A familial case of Marfan syndrome: a novel variant in the FBN1 gene
Journal: RUDN Journal of Medicine (Vol.29, No. 4)Publication Date: 2025-12-18
Authors : Vsevolod Stepanenko; Irina Zhalsanova; Elizaveta Fonova; Daria Erburova; Sofia Gosudarkina; Ekaterina Ravzhaeva; Svetlana Fadyushina; Anastasiya Nikitina; Gulnara Seitova; Olesya Klimchuk; Vadim Stepanov; Nikolay Skryabin;
Page : 470-479
Keywords : Marfan syndrome; FBN1; hereditary connective tissue disorders; next-generation sequencing;
Abstract
Marfan syndrome is a hereditary connective tissue disorder characterized by marked pleiotropy and clinical variability. The main disease manifestations involve three systems: skeletal, ocular, and cardiovascular. The condition is caused by pathogenic variants in the FBN1 gene, which encodes fibrillin-1, a protein essential for the formation and maintenance of the extracellular matrix. This article describes a familial case (the proband and his father) with clinical manifestations of Marfan syndrome. Whole-genome sequencing of the proband and his father revealed a previously unreported variant, c.5782T>A, p.(Cys1928Ser), in the FBN1 gene. Thus, a molecular genetic diagnosis of Marfan syndrome was established by identifying this novel pathogenic variant. Conclusion. A confirmed diagnosis at both the clinical and molecular genetic levels in both patients determines the further therapeutic strategy and enables timely primary and secondary disease prevention within the family.
Other Latest Articles
- Biological and psychological approach to familial hypercholesterolemia
- Neuroprotective effect of extracellular vesicles obtained from human glial derivatives on the model of glutamate excitotoxicity
- Single cell RNA sequencing: modern approaches and achievements
- Deep Learning Based Histopathological Classification of Cervical Cancer Using YOLO-v8 and Inception-v3: A Comparative Performance Study
- Impact of Working Capital Management on a Firm’s Profitability: A Study on Bharti Airtel
Last modified: 2025-12-18 08:34:23
Share Your Research, Maximize Your Social Impacts


